|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, February 13, 2017 ) Europe Multiple Myeloma Therapeutics Market is projected to reach USD 2.25 Billion by 2021, at a CAGR of 4.58% from 2016 to 2021.
For full report refer to http://www.marketdataforecast.com/market-reports/europe-multiple-myeloma-therapeutics-market-860/
Free sample for the report is available at http://www.marketdataforecast.com/market-reports/europe-multiple-myeloma-therapeutics-market-860/request-sample
The Multiple Myeloma (MM) market is presently dominated by Velcade and Revlimid, and the market is set to experience considerable growth between 2016 and 2021. As multiple myeloma is mostly irredeemable and is regularly characterised by a cycle of reduction and relapse, there is an acute need for new treatments for patients that work in distinctive and innovative ways.
Improved investments in R&D in the pharmaceutical area, absence of healing drugs for blood diseases and the introduction of advanced drugs have fuelled the growth of multiple myeloma therapeutics market. Therapies such as radiation therapy, chemotherapy, physiotherapy, and biological therapy have huge potential to outgrowth the market.
Enquire more about the report at http://www.marketdataforecast.com/market-reports/europe-multiple-myeloma-therapeutics-market-860/inquire
Segmentation:
By Treatment Type:
Chemotherapy
Anthracycline antibiotic
Melphalan (Alkeran)
Liposomal doxorubicin (Doxil)
Alkylating agent
Doxorubicin (Adriamycin)
Cyclophosphamide (Neosar)
Vincristine (Oncovin)
Carmustine (BiCNU)
Targeted therapy
Proteasome inhibitor
Bortezomib (Velcade)
Carfilzomib (Kyprolis)
By Drug Type
Corticosteroids
Dexamethasone (Decadron)
Prednisone (Deltasone/Orasone)
Immunomodulatory agents
Thalidomide (Thalomid)
Lenalidomide (Revlimid)
Arsenic trioxide (Trisenox)
Plerixafor (Mozobil)
By Region
U.K
Spain
Germany
Italy
France
Some of the key contributors in the industry include AB Science SA, AbbVie Inc., Ablynx NV, Acceleron Pharma Inc., IGF Oncology LLC. , ImmunGene Inc., Millennium Pharmaceuticals Inc., MimiVax LLC, Mirna Therapeutics, RedHill Biopharma Ltd., Rhizen Pharmaceuticals S.A., Terpenoid Therapeutics Inc. ,Teva Pharmaceutical Industries Ltd. ,TG Therapeutics Inc. and Johnson and Johnson.
Buy now http://www.marketdataforecast.com/cart/buy-now/europe-multiple-myeloma-therapeutics-market-860
The Europe Multiple Myeloma Therapeutics Market Study covers:
Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
Study the micro environment factors that determine the overall profitability of an Industry, using Porters five forces analysis for analysing the level of competition and business strategy development
A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Checkout other related studies in the Therapeutics Segment:
Europe Radiotherapy Market: http://www.marketdataforecast.com/research-reports/healthcare/therapeutics-11/market-reports/europe-radiotherapy-market-817/
Europe Autoimmune Monoclonal Antibodies Market: http://www.marketdataforecast.com/research-reports/healthcare/therapeutics-11/market-reports/europe-autoimmune-monoclonal-antibodies-1172/
Europe Monoclonal Antibodies: http://www.marketdataforecast.com/market-reports/europe-monoclonal-antibodies-market-1186/
Europe Neurotherapeutics Market: http://www.marketdataforecast.com/research-reports/healthcare/therapeutics-11/market-reports/europe-neurotherapeutics-market-1272/
Europe Immunotherapy Drugs Market: http://www.marketdataforecast.com/research-reports/healthcare/therapeutics-11/market-reports/europe-cancer-immunotherapy-market-1414/
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
Market Data Forecast
Abhishek
+1-888- 702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
